Legal & General Group PLC Akero Therapeutics, Inc. Transaction History

Legal & General Group PLC

  • $368 Billion
  • Q4 2024

A detailed history of Legal & General Group PLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 50,080 shares of AKRO stock, worth $2.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,080
Previous 55,562 9.87%
Holding current value
$2.38 Million
Previous $1.59 Million 12.61%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$26.75 - $35.28 $146,643 - $193,404
-5,482 Reduced 9.87%
50,080 $1.39 Million
Q3 2024

Nov 14, 2024
SELL
$21.45 - $29.34 $23,616 - $32,303
-1,101 Reduced 1.94%
55,562 $1.59 Million
Q2 2024

Aug 14, 2024
BUY
$18.31 - $24.62 $123,336 - $165,840
6,736 Added 13.49%
56,663 $1.33 Million
Q1 2024

May 14, 2024
BUY
$17.76 - $31.18 $120,590 - $211,712
6,790 Added 15.74%
49,927 $1.26 Million
Q4 2023

Feb 15, 2024
SELL
$11.38 - $50.33 $1,274 - $5,636
-112 Reduced 0.26%
43,137 $1.01 Million
Q3 2023

Nov 14, 2023
BUY
$41.19 - $52.25 $118,833 - $150,741
2,885 Added 7.15%
43,249 $2.19 Million
Q2 2023

Aug 14, 2023
BUY
$36.89 - $56.88 $404,941 - $624,371
10,977 Added 37.35%
40,364 $1.88 Million
Q1 2023

May 15, 2023
BUY
$37.27 - $50.24 $602,208 - $811,777
16,158 Added 122.14%
29,387 $1.12 Million
Q4 2022

Feb 14, 2023
BUY
$33.44 - $54.8 $100,085 - $164,016
2,993 Added 29.24%
13,229 $724,000
Q3 2022

Nov 14, 2022
BUY
$10.15 - $34.05 $27,993 - $93,909
2,758 Added 36.88%
10,236 $349,000
Q2 2022

Aug 22, 2022
BUY
$8.0 - $15.01 $4,552 - $8,540
569 Added 8.24%
7,478 $71,000
Q4 2021

Feb 14, 2022
BUY
$19.87 - $26.24 $834 - $1,102
42 Added 0.61%
6,909 $146,000
Q3 2021

Nov 15, 2021
BUY
$18.65 - $25.46 $57,591 - $78,620
3,088 Added 81.71%
6,867 $153,000
Q2 2021

Aug 12, 2021
BUY
$24.81 - $32.35 $35,255 - $45,969
1,421 Added 60.26%
3,779 $93,000
Q1 2021

May 17, 2021
SELL
$24.04 - $34.19 $1,730 - $2,461
-72 Reduced 2.96%
2,358 $69,000
Q3 2020

Nov 13, 2020
BUY
$30.79 - $39.92 $18,042 - $23,393
586 Added 31.78%
2,430 $75,000
Q2 2020

Aug 14, 2020
BUY
$19.25 - $26.76 $10,857 - $15,092
564 Added 44.06%
1,844 $46,000
Q1 2020

May 14, 2020
BUY
$12.8 - $27.05 $4,736 - $10,008
370 Added 40.66%
1,280 $27,000
Q4 2019

Feb 13, 2020
BUY
$17.37 - $27.27 $2,622 - $4,117
151 Added 19.89%
910 $20,000
Q3 2019

Nov 13, 2019
BUY
$16.89 - $29.88 $12,819 - $22,678
759 New
759 $17,000

Others Institutions Holding AKRO

# of Institutions
210
Shares Held
74.3M
Call Options Held
321K
Put Options Held
558K
View Full List

About Akero Therapeutics, Inc.

AKRO Quotes by TradingView
  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $2.2B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email